Blood test could predict lupus flares

NCT ID NCT00920114

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study aims to develop a more objective way to measure lupus disease activity using a blood test that analyzes gene activity. Researchers will compare this gene-based score with standard clinical assessments in 80 lupus patients. The goal is to create a non-invasive tool to better track and forecast the disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a simple blood test to more accurately track lupus activity and forecast flares.

What could go wrong

This is a small, observational study focused on developing a measurement tool, not a treatment. The gene-based score may not prove reliable in larger, diverse groups.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUPUS DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lupus erythematosus systemic lupus erythematosus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Assistance Publique-Hopitaux de Marseille

    Marseille, France